BsUFA III commitment letter details FDA, industry goals for biosimilars program
Regulatory NewsMichael Mezher
Biologics/ biosimilars/ vaccinesHealth Authority meeting and communication strategyNorth AmericaRegulatory Intelligence/PolicyRegulatory NewsMichael MezherBiologics/ biosimilars/ vaccinesHealth Authority meeting and communication strategyNorth AmericaRegulatory Intelligence/Policy